Ogiso T, Iwaki M, Tanino T, Okuyama K, Uno S
Faculty of Pharmaceutical Sciences, Kinki University, Osaka, Japan.
Biol Pharm Bull. 1993 Feb;16(2):163-7. doi: 10.1248/bpb.16.163.
In an attempt to clarify the possible mechanism of the interaction between theophylline (TP) and mexiletine (ME), the elimination kinetics and in vitro metabolism of TP and its metabolites were investigated in rats. The plasma elimination of TP, 1,3-dimethyluric acid (1,3-DMU) and 1-methyluric acid (1-MU) was significantly delayed by the intravenous (i.v.) administration of ME. The oral administration of ME also decreased the elimination rate of TP to the same extent as the i.v. dosing. The in vitro metabolic experiment showed that ME significantly inhibited the metabolic conversion of TP to 1,3-DMU and, 1,3-DMU to 1-MU, and slightly inhibited the conversion of TP to 3-methylxanthine, these processes being mediated by microsomal enzymes, with no inhibition of xanthine oxidase. Our results indicated that ME could inhibit the metabolic conversion of TP and its metabolite in rat, as reported in man.
为了阐明茶碱(TP)与美西律(ME)之间相互作用的可能机制,对大鼠体内TP及其代谢产物的消除动力学和体外代谢进行了研究。静脉注射ME可显著延迟TP、1,3 - 二甲基尿酸(1,3 - DMU)和1 - 甲基尿酸(1 - MU)的血浆消除。口服ME也使TP的消除率降低至与静脉给药相同的程度。体外代谢实验表明,ME显著抑制TP向1,3 - DMU的代谢转化以及1,3 - DMU向1 - MU的代谢转化,并轻微抑制TP向3 - 甲基黄嘌呤的转化,这些过程由微粒体酶介导,且对黄嘌呤氧化酶无抑制作用。我们的结果表明,与在人体中的报道一样,ME可抑制大鼠体内TP及其代谢产物的代谢转化。